Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients
NCT03662789
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
102
Enrollment
OTHER
Sponsor class
Conditions
Heart Transplant Recipients
Interventions
DRUG:
Iron Isomaltoside 1000
OTHER:
Placebo: NaCl 0,9%
Sponsor
Oslo University Hospital
Collaborators
[object Object]